Inloggen
E-mail
Wachtwoord
Paswoord weergeven
Bewaren
Bent u uw wachtwoord vergeten?
Gratis lid worden
Registreer
Registreer
Instellingen
Instellingen
Dynamische koersen 
OFFON

ONO PHARMACEUTICAL CO., LTD.

(4528)
OverzichtKoersenGrafiekenNieuwsRatingsAgendaOndernemingFinanciŽnConsensusHerzieningenBeursproducten 
OverzichtAl het nieuwsAndere talenPersberichtenOfficiŽle publicatiesSectornieuws
Communiquťs de presse de la sociťtť ONO PHARMACEUTICAL CO., LTD.
06/01Ono Pharmaceutical Co., Ltd. - Opdivo Intravenous Infusion Approved for the Adjuvant Tr..
AQ
2021Ono Extends Drug Discovery Collaboration Agreement with Vanderbilt University
AQ
2021ONO Pharmaceutical Announces the Foundation of 'ONO Pharmaceutical and Dr. Honjo Honora..
AQ
2021ONO Selected as a Highest Rating A-List Company for Both 'Climate Change' and 'Water Se..
AQ
2021Ono Announces Status of Acquisition of Own Shares
AQ
2021R & D - ONO Receives Approval of Opdivo (nivolumab) for Expanded Use for Two Indication..
AQ
2021ONO Announces the Settlement of Litigation Raised by Dr. Honjo
AQ
2021Ono Pharmaceutical Co. - Velexbru Tablet 80 mg, a BTK inhibitor, Approved in South Kore..
AQ
2021ONO Submits an Application of ONOACT for Intravenous Infusion 50mg/150mg
AQ
2021Exelixis Announces Partner Takeda and Ono Receive Approval in Japan for CABOMETYX (cabo..
AQ
2021ONO PHARMACEUTICAL : Corporate Governance Report
PU
2021ONO PHARMACEUTICAL : Announcement of New Office Establishment of U.S. Subsidiary (ONO PHAR..
AQ
2021ONO PHARMACEUTICAL : Helsinn Announces the Launch of Adlumiz (anamorelin) for the Treatmen..
AQ
2021ONO PHARMACEUTICAL : Submits Supplemental Application for Approval for Opdivo (Nivolumab) ..
AQ
2021ONO PHARMACEUTICAL : Bristol Myers Squibb Announces Opdivo (nivolumab) plus Chemotherapy a..
AQ
2021ONO PHARMACEUTICAL : Announcement on Changes of Members of the Board of Directors, Audit &..
AQ
2021BRISTOL MYERS SQUIBB : Ono Pharmaceutical Co., Ltd - European Medicines Agency Validates B..
AQ
2021ONO PHARMACEUTICAL : Joins the University of California Drug Discovery Consortium
AQ
2021ONO PHARMACEUTICAL : Received 'Osaka Governor's Award' of the Osaka Stop Global Warming Aw..
AQ
2021ONO PHARMACEUTICAL : and Seikagaku Announce a Manufacturing and Marketing Approval in Japa..
AQ
2021ONO PHARMACEUTICAL : Entered License Agreement with PeptiDream Inc. on Automated Peptide D..
AQ
2021ONO PHARMACEUTICAL : Entered Sponsorship Agreements with LabCentral and MBC BioLabs
AQ
2021ONO PHARMACEUTICAL : Submits Supplemental Application for Approval for Opdivo to Expand th..
AQ
2021ONO PHARMACEUTICAL : Statement concerning Prosecution of Employees
AQ
2021ONO PHARMACEUTICAL : U.S. Food and Drug Administration Accepts for Priority Review Applica..
AQ
2021ONO PHARMACEUTICAL : enters into License Agreement with Ribon Therapeutics for the Develop..
AQ
2021ONO PHARMACEUTICAL : Announces Transfer of the Manufacturing and Marketing Approval Author..
AQ
2021ONO PHARMACEUTICAL : Notice concerning the Establishment of Ono Pharma Healthcare Co., Ltd..
AQ
2021ONO PHARMACEUTICAL : Statement concerning Arrest of Employees
AQ
2021ONO PHARMACEUTICAL : Submits Supplemental Application for Approval of Opdivo to Expand the..
AQ
2021ONO PHARMACEUTICAL : Helsinn Group - ONO Receives a Manufacturing and Marketing Approval o..
AQ
2021ONO PHARMACEUTICAL : Notice on the Adopter of the 'Osamu Hayaishi Memorial Scholarship for..
AQ
2020ONO PHARMACEUTICAL : Enters into Exclusive License Agreement with Chordia Therapeutics on ..
AQ
2020ONO PHARMACEUTICAL : Submits Supplemental Application for Approval for Opdivo to Expand th..
AQ
2020BRISTOL MYERS SQUIBB : Ono Pharmaceutical - Combination Therapy concerning Opdivo and Yerv..
AQ
2020ONO PHARMACEUTICAL : Receives Approval of BRAFTOVI Capsule, a BRAF Inhibitor and MEKTOVI T..
AQ
2020BRISTOL MYERS SQUIBB : Receives European Commission Approval for Opdivo as Second-Line Tre..
AQ
2020ONO PHARMACEUTICAL : Selected for the First Time for DJSI World Index and DJSI Asia Pacifi..
AQ
2020ONO PHARMACEUTICAL : FOIPAN Tablets, a Protease Enzyme Inhibitor, Started Clinical Study i..
AQ
2020Licensing, ONO and Bristol Myers Squibb Enter Patent License Agreement with Roche
AQ
2020ONO PHARMACEUTICAL : and BMSKK Submit Supplemental Applications for Opdivo and Yervoy in C..
AQ
2020Ono and Takeda Submit Supplemental Application for Opdivo and CABOMETYX Combination The..
AQ
2020Exelixis Announces Takeda and Ono Submit Supplemental Application for CABOMETYX in Comb..
AQ
2020RAFAEL : A New Phase 1 Study Began to Evaluate Rafael Pharmaceuticals Lead Compound CPI-61..
AQ
2020SK Biopharmaceuticals, Ono Pharmaceutical Enter Licensing Agreement for Cenobamate in J..
AQ
2020Ono Enters into License Agreement on Cenobamate, an Antiepileptic Drug with SK Biopharm..
AQ
2020ONO PHARMACEUTICAL : To Whom Do Joint Research Results Belong? Current Situation And Issue..
AQ
2020ONO PHARMACEUTICAL : Phase III Study Result Evaluating Opdivo in Combination with Bevacizu..
AQ
2020ONO PHARMACEUTICAL : Phase II / III Study Result Evaluating Opdivo in Combination with Che..
AQ
2020ONO PHARMACEUTICAL : Launch of Ongentys Tablets 25mg, a Peripheral COMT Inhibitor in Japan
AQ
2020ONO PHARMACEUTICAL : Federal Circuit Finds Significant Contributions For Co-Inventorship
AQ
2020ONO PHARMACEUTICAL : Development of Therapeutic Drugs for Novel Coronavirus Infection
AQ
2020THEN YOU DIDN'T SEE THEM; NOW YOU DO : Co-Inventors Added
AQ
2020ONO PHARMACEUTICAL : Independently Performed, Publicly Disclosed Prior Work Can Lead To Jo..
AQ
2020ONO PHARMACEUTICAL : Federal Circuit Confirms Joint Inventorship On Nobel Prize Winner's C..
AQ
2020ONO PHARMACEUTICAL : Federal Circuit Confirms Joint Inventorship On Nobel Prize Winner's C..
AQ
2020ONO PHARMACEUTICAL : Federal Circuit Confirms Addition Of Two Inventors Of Groundbreaking ..
AQ
2020ONO PHARMACEUTICAL : Selected for 'MSCI Japan ESG Select Leaders Index' for the 2nd consec..
AQ
2020ONO PHARMACEUTICAL : Support for Relief Efforts to the Disaster Caused by Heavy Rain in Ju..
AQ
2020ONO PHARMACEUTICAL : Notice regarding Filing an Appeal for a Lawsuit against the Company
AQ
2020ONO PHARMACEUTICAL : Notice Concerning Determination of Details of Issuance of Stock Optio..
AQ
2020ONO PHARMACEUTICAL : Receives a Manufacturing and Marketing Approval in Japan of 'Ongentys..
AQ
2020ONO PHARMACEUTICAL : A Short-Acting Selective 1 Blocker, Onoact for Intravenous Infusion 5..
AQ
2020ONO PHARMACEUTICAL : Nobel laureate Honjo sues Ono Pharmaceutical over patent royalties
AQ
2020ONO PHARMACEUTICAL : and Seikagaku Announce the Results from a Phase III Clinical Study in..
AQ
2020ONO PHARMACEUTICAL : Joins RE100, an International Initiative Aiming to Use 100% Renewable..
AQ
2020BRISTOL MYERS SQUIBB : Ono Pharmaceutical Co., Ltd. - Opdivo Intravenous Infusion Approved..
AQ
2020ONO PHARMACEUTICAL : FOIPAN Tablets, a Protease Enzyme Inhibitor, ONO Has Started Clinical..
AQ
2020ONO PHARMACEUTICAL : establishes a specified subsidiary and a local subsidiary in the US
AQ
2020Bristol Myers Squibb and Exelixis Announce Positive Topline Results from Pivotal Phase ..
AQ
2020Ono and Takeda Announce Results from Phase 3 CheckMate -9ER Study for Opdivo and CABOME..
AQ
2020BRISTOL MYERS SQUIBB : Announces Acceptance of U.S. and EU Regulatory Filings for Opdivo P..
AQ
2020ONO PHARMACEUTICAL : Announcement on Election of Provisional Audit and Supervisory Board M..
AQ
2020ONO PHARMACEUTICAL : Announcement on Candidates of Members of the Board of Directors, Memb..
AQ
2020ONO PHARMACEUTICAL : Enters into a New Research and Option Agreement with Numab
AQ
1  2  3  4  5  6Volgende
Volgende evenement op ONO PHARMACEUTICAL CO., LTD.
31/01/22